Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells

FEBS Lett. 1998 Aug 14;433(1-2):161-5. doi: 10.1016/s0014-5793(98)00898-9.

Abstract

Lysophosphatidylcholine (lyso-PC) accumulates in tissues undergoing inflammation and atherosclerosis, where an infiltration of T cells is also seen. We found that lyso-PC increased IFN-gamma production and CD40L expression in CD4+ T cells stimulated with anti-CD3 Ab and recombinant CD80 molecules, whereas lyso-PC did not affect IL-2 and IL-4 production. These results suggest that lyso-PC, in combination with other stimuli, may regulate CD4+ T cell functions to propagate local inflammatory reactions and also imply a novel role played by a modified lipid in the selection of Th1/Th2 immune response as well as in the T cell mediated pathogenesis in atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / pharmacology
  • B7-1 Antigen / immunology
  • CD3 Complex / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism*
  • CD40 Ligand
  • Cell Line
  • Coculture Techniques
  • Gene Expression Regulation / drug effects*
  • Humans
  • Interferon-gamma / biosynthesis
  • Lymphocyte Activation
  • Lysophosphatidylcholines / pharmacology*
  • Membrane Glycoproteins / genetics*
  • RNA, Messenger / metabolism
  • Recombinant Proteins / immunology

Substances

  • Antibodies
  • B7-1 Antigen
  • CD3 Complex
  • Lysophosphatidylcholines
  • Membrane Glycoproteins
  • RNA, Messenger
  • Recombinant Proteins
  • CD40 Ligand
  • Interferon-gamma